Therefore, therapeutic approaches for Alzheimer’s disease (AD) were established in the form of inhibitors of AChE (acetylcholinesterase) and BChE (butyrylcholinesterase). The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.